Homologous recombination repair gene mutations predict the efficacy of immune checkpoint inhibitors therapy in colorectal cancer

被引：0
|
作者：
Lin, Y. [1 ]
Zhang, J. [1 ]
Liao, X. [1 ]
Zhang, Y. [1 ]
Luo, M. [1 ]
Li, Q. [1 ]
Xie, M. [1 ]
Liang, C. [1 ]
Liao, S. [1 ]
Zheng, Y. [2 ]
Hu, X. [2 ]
Huang, M. [2 ]
Liang, R. [1 ]
Li, Y. [1 ]
机构：
[1] Guangxi Med Univ, Canc Hosp, Digest Oncol, Nanning, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.970
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
449P
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of neoadjuvant immune checkpoint inhibitors in patients with localized mismatch repair deficient colorectal cancer: A systematic review.
    Grewal, Udhayvir Singh
    Vora, Kruti Bhagirath
    Parikh, Aparna Raj
    Mahipal, Amit
    Chakrabarti, Sakti
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 149 - 149
  • [42] DNAH7 mutations benefit colorectal cancer patients receiving immune checkpoint inhibitors
    Yang, Wenjuan
    Shen, Zhengjie
    Yang, Ti
    Wu, Mianhua
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (24)
  • [43] Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors
    Zhao, Diwei
    Wang, Anqi
    Li, Yuanwei
    Cai, Xinyang
    Zhao, Junliang
    Zhang, Tianyou
    Zhao, Yi
    Dong, Yu
    Zhou, Fangjian
    Li, Yonghong
    Wang, Jun
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (03): : 280 - 287
  • [44] The Role of Immune Checkpoint Inhibitors in Cancer Therapy
    Basudan, Ahmed M.
    CLINICS AND PRACTICE, 2023, 13 (01) : 22 - 40
  • [45] Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer
    Emiloju, Oluwadunni E.
    Sinicrope, Frank A.
    JAMA ONCOLOGY, 2023, 9 (12) : 1708 - 1715
  • [46] Identification and validation of significant gene mutations to predict clinical benefit of immune checkpoint inhibitors in lung adenocarcinoma
    Chen, Ying
    Miao, Shaoyi
    Zhao, Wancheng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (03): : 1051 - 1063
  • [47] Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer
    Liu, Chao
    Xiao, Huiting
    Cui, Luying
    Fang, Lin
    Han, Shuling
    Ruan, Yuli
    Zhao, Wenyuan
    Zhang, Yanqiao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Therapy of rectal cancer and DNA mismatch repair deficiency using immune checkpoint inhibitors
    Lauscher, Johannes Christian
    COLOPROCTOLOGY, 2022, 44 (06) : 423 - 424
  • [49] Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer
    Wilson, Andrew J.
    Gupta, Vijayalaxmi G.
    Liu, Qi
    Yull, Fiona
    Crispens, Marta A.
    Khabele, Dineo
    NEOPLASIA, 2022, 24 (02): : 63 - 75
  • [50] Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors
    Lee, Minyi
    Eng, George
    Barbari, Stephanie R.
    Deshpande, Vikram
    Shcherbakova, Polina, V
    Gala, Manish K.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 : e00149
12345